Inventaire - your friends and communities are your best library - Inventaire

Pharmacology of imatinib (STI571).

published in: European Journal of Cancer

date of publication: 2002-09-01

main subject: pharmacology, imatinib

Cites articles 26

Date

Title

Authors

2001-04-05

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
2001-10-01

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
2001-04-01

ARG tyrosine kinase activity is inhibited by STI571.
2001-01-01

Involvement of platelet-derived growth factor in disease: development of specific antagonists
2001-05-01

Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes
2001-05-01

Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

Marco A. Pierotti, Angela Greco, Loredana Cleris
2001-05-01

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
2001-08-01

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
2000-11-01

The protein tyrosine kinase family of the human genome

Su-Fang Lin
2000-01

The Hallmarks of Cancer

Douglas Hanahan, Robert Weinberg
2000-11-01

Development of inhibitors for protein tyrosine kinases
2000-10-01

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

Agnieszka Wozniak, Aziza Nassar, L. H. Sobin, Markku Miettinen, Jerzy Lasota, Radzisław Kordek
2000-03-01

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
1999-06-01

Activating c-kit gene mutations in human germ cell tumors
1998-01-23

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
1997-01-01

A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein
1996-05

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
1996-08-01

A novel physiological function for platelet-derived growth factor-BB in rat dermis

Rolf K Reed
1996-02-01

Delivery of molecular medicine to solid tumors
1995-01-01

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.
1993-07-01

Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant

Bengt Westermark
1993-12-01

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells
1993-01-01

Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts
1990-02-01

Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF.

Donald Gullberg
1990-09-01

A critical appraisal of the predictive value of in vitro chemosensitivity assays

Roger M. Phillips
1989-06-01

Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice

Article - wd:Q33963732

Welcome to Inventaire

the library of your friends and communities

you are offline